1832 Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

1832 Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,500	Closed	-$1.19M	–	746
2018 Q4	$1.19M	Sell	8,500 -5,800	-41%	-$880K	﹤0.01%	402
2018 Q3	$2.44M	Buy	14,300 +1,400	+11%	+$235K	0.01%	362
2018 Q2	$2.24M	Buy	+12,900	New	+$1.94M	0.01%	365

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

1832 Asset Management's LOXO Position: Q1 2019 in Review

1832 Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 8,500 shares — an estimated $1.19M sold.

1832 Asset Management first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $2.44M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

1832 Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
1832 Asset Management sold 8,500 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.19M.
1832 Asset Management first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
1832 Asset Management's Loxo Oncology, Inc position peaked at $2.44M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on 1832 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.